Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications
- Products
-
- Metoprolol Succinate Extended-Release Tablets
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 19,056 bottles
- About this recall
- Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11